Results 1 to 10 of about 100,682 (160)
Role of biofilm formation and antimicrobial resistance in urogenital Haemophilus influenzae isolates [PDF]
BMC MicrobiologyBackground Haemophilus influenzae (Hi) is increasingly detected in genital infections in humans and linked to septic abortion. We aimed to characterize 123 non-capsulated (non-typeable) Hi isolates from genital sites in women and investigate their ...
Nouria Belkacem +4 more
doaj +2 more sources
Multi-Component Vaccine Candidates Against Non-Typeable Haemophilus influenzae [PDF]
VaccinesBackground: Haemophilus influenzae (Hi), a Gram-negative bacterium, is divided into two broad categories: encapsulated and non-capsulated isolates, also called non-typeable Hi isolates (NTHi).
Nouria Belkacem +2 more
doaj +2 more sources
Case Report: An endogenous endophthalmitis case caused by Haemophilus influenzae [PDF]
Frontiers in MedicineHaemophilus influenzae is a bacterium that typically colonizes the human respiratory tract. However, it can also infect the eyes, potentially leading to endophthalmitis.
Chia Hsuan Tsai +6 more
doaj +2 more sources
Human Neutrophil Elastase Degrades SPLUNC1 and Impairs Airway Epithelial Defense against Bacteria [PDF]
, 2013 Background:Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are a significant cause of mortality of COPD patients, and pose a huge burden on healthcare. One of the major causes of AECOPD is airway bacterial (e.g.
Bowler, RP +5 more
core +20 more sources
Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules
BMC Infectious Diseases, 2021 Background Haemophilus influenzae serotype b (Hib) conjugate vaccine was introduced in France in 1992 as a 3 + 1 scheme at 2, 3, and 4 months (primary vaccination) with a booster at the age of 16–18 months. The vaccination was simplified in 2013 to a 2 +
Eva Hong +6 more
doaj +1 more source
npj Vaccines, 2022 Since January 2018, mandatory vaccination against meningococci serogroup C has been implemented in France for children
Samy Taha +2 more
doaj +1 more source
Product review on the IMD serogroup B vaccine Bexsero®
Human Vaccines & Immunotherapeutics, 2022 Bexsero® is a multicomponent vaccine composed of four major proteins of Neisseria meningitidis: the fHbp, NHBA, NadA and PorA. This vaccine was licensed against invasive meningococcal disease (IMD) due to serogroup B isolates.
Ala-Eddine Deghmane, Muhamed-Kheir Taha
doaj +1 more source
Frontiers in Microbiology, 2023 BackgroundNon-typeable Haemophilus influenzae has become increasingly important as a causative agent of invasive diseases following vaccination against H. influenzae type b.
Esra Ekinci +13 more
doaj +1 more source
Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease
BMC Research Notes, 2020 Objective Few data are available on the association between SARS-CoV-2 and secondary bacterial infections. Such an association was described for flu and invasive meningococcal disease (IMD).
Muhamed-Kheir Taha, Ala-Eddine Deghmane
doaj +1 more source
Analysis of Haemophilus species in patients with respiratory tract infections in Yaoundé, Cameroon
International Journal of Infectious Diseases, 2020 Objectives: To identifyHaemophilus species and characterise the antimicrobial susceptibility of isolates from patients with respiratory tract infections (RTIs) in Cameroon.
Serges Tchatchouang +11 more
doaj +1 more source